AI-guided microscope for basal cell skin cancer surgery
Part of Cancer clinical trials.
This trial tests a special microscope that uses artificial intelligence (AI) to help surgeons see exactly where skin cancer (basal cell carcinoma) ends during surgery. This could help remove all cancer cells in one go, making repeat surgeries less likely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with basal cell carcinoma (a type of skin cancer).
- You can understand and give your own permission (consent) for the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging tool called LC-OCT to see if it helps doctors remove all skin cancer during Mohs surgery. It might reduce the need for extra surgeries by giving clearer pictures in real time.
This study uses artificial intelligence to analyze magnified skin images of basal cell carcinoma to predict the cancer's subtype and risk classification. It aims to improve diagnosis and treatment planning without additional procedures.
This trial is testing a new microscope technique that may help doctors see more clearly whether all cancer cells have been removed during standard skin cancer surgery. It could help make sure the surgery is successful the first time.
This study is testing a new imaging technology that helps surgeons see if all the cancer cells have been removed during Mohs surgery for basal cell carcinoma. It may help improve accuracy and reduce the need for additional surgeries.
This trial uses an advanced AI-assisted imaging device to see the edges of a common skin cancer called basal cell carcinoma before surgery. It may help doctors remove the cancer more precisely, possibly reducing the need for repeat procedures.
This study uses artificial intelligence to help diagnose basal cell carcinoma, a common type of skin cancer, from digital images of tissue samples. It may improve accuracy and speed of diagnosis.
Hear when a new Basal Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.